DDW Editor Reece Armstrong speaks to Christine MacCracken, Executive Director of Patient Strategies & Solutions at Johnson & Johnson Innovative Medicine, about expanded access strategies and the company’s decision to create a guide to help reduce barriers to investigational medicines for seriously or terminal ill patients. RA: Why are expanded access pathways currently difficult to […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!
